Alpenglow Biosciences and CorePlus partner together to bring 3D Spatial Biology to clinical research and development

Written By Elisa Barbieri

Alpenglow today announced a partnership with CorePlus, a high complexity CLIA-certified clinical and anatomic pathology laboratory, to digitize and analyze tissues in 3D to deliver novel spatial biology insights and accelerate drug development.

As part of the partnership, CorePlus will invest an undisclosed sum into Alpenglow and receive access to Alpenglow's 3Deep Imager, a patented hybrid open-top light-sheet imaging platform.

Elisa Barbieri
Previous

Alpenglow Biosciences and Mayo Clinic enter a collaboration agreement to advance pathology and drug development.